EFFECT OF CO-ADMINISTRATION OF URACIL OR CYTOSINE ON THE ANTI-TUMOR ACTIVITY OF CLINICAL DOSES OF 1-(2-TETRAHYDROFURYL)-5-FLUOROURACIL AND LEVEL OF 5-FLUOROURACIL IN RODENTS

被引：0
|
作者：
FUJII, S
KITANO, S
IKENAKA, K
SHIRASAKA, T
机构：
来源：
GANN | 1979年 / 70卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：209 / 214
页数：6
相关论文
共 50 条
  • [41] GENERAL PHARMACOLOGICAL PROPERTIES OF UFT, A NEW TYPE OF ANTICANCER AGENT CONSISTING OF 1-(2-TETRAHYDROFURYL)-5-FLUOROURACIL (FT) AND URACIL .1. PHARMACOLOGICAL ANALYSIS OF THE COMBINED EFFECT OF FT AND URACIL
    YAMAMOTO, J
    TOIDE, K
    HARUNO, A
    YOSHIMURA, Y
    UNEMI, N
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1981, 31-2 (08): : 1268 - 1278
  • [42] ALTERED PHARMACODYNAMICS OF 1-(2-TETRAHYDROFURYL)-5-FLUOROURACIL BY PRETREATMENT OF RATS WITH PHENOBARBITAL, INDOMETHACIN, DICLOFENAC SODIUM AND CARBON-TETRACHLORIDE
    HOBARA, N
    WATANABE, A
    PHARMACOLOGY, 1980, 21 (05) : 323 - 326
  • [43] THE INFLUENCE OF AMINAZINE AND PHENAZEPAM ON TOXICITY AND ANTI-TUMOR ACTIVITY OF FTORAFUR AND 5-FLUOROURACIL
    SUSLOV, NI
    MIKHAILOVA, LM
    EKSPERIMENTALNAYA ONKOLOGIYA, 1983, 5 (02): : 70 - 73
  • [44] Enhanced therapeutic anti-tumor immunity induced by co-administration of 5-fluorouracil and adenovirus expressing CD40 ligand
    Liljenfeldt, Lina
    Gkirtzimanaki, Katerina
    Vyrla, Dimitra
    Svensson, Emma
    Loskog, Angelica S. I.
    Eliopoulos, Aristides G.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2014, 63 (03) : 273 - 282
  • [45] Enhanced therapeutic anti-tumor immunity induced by co-administration of 5-fluorouracil and adenovirus expressing CD40 ligand
    Lina Liljenfeldt
    Katerina Gkirtzimanaki
    Dimitra Vyrla
    Emma Svensson
    Angelica SI Loskog
    Aristides G. Eliopoulos
    Cancer Immunology, Immunotherapy, 2014, 63 : 273 - 282
  • [46] RELATIONSHIP BETWEEN ANTI-TUMOR EFFECT AND METABOLITES OF 5-FLUOROURACIL IN COMBINATION TREATMENT WITH 5-FLUOROURACIL AND GUANOSINE IN ASCITES SARCOMA-180 TUMOR SYSTEM
    IIGO, M
    KURETANI, K
    HOSHI, A
    CANCER RESEARCH, 1983, 43 (12) : 5687 - 5694
  • [47] ENHANCED ACCUMULATION OF 5-FLUOROURACIL IN HUMAN-TUMORS IN ATHYMIC MICE BY CO-ADMINISTRATION OF FTORAFUR AND URACIL
    TANG, SG
    HORNBECK, CL
    BYFIELD, JE
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1984, 10 (09): : 1687 - 1689
  • [48] EFFECT OF N1-(2'-TETRAHYDROFURYL)-5-FLUOROURACIL AND 5-FLUOROURACIL ON NUCLEIC-ACID AND PROTEIN BIOSYNTHESES IN EHRLICH ASCITES-CELLS
    FUJIMOTO, S
    AKAO, T
    ITOH, B
    KOSHIZUKA, I
    KOYANO, K
    KITSUKAWA, Y
    TAKAHASHI, M
    MINAMI, T
    ISHIGAMI, H
    NOMURA, Y
    ITOH, K
    CANCER RESEARCH, 1976, 36 (01) : 33 - 36
  • [49] PREVENTION OF 5-FLUOROURACIL (5-FU)-INDUCED LEUKOPENIA WITH ENHANCEMENT OF ANTI-TUMOR ACTIVITY
    STOLFI, RL
    SPIEGELMAN, S
    MARTIN, DS
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 192 - 192
  • [50] COMPARATIVE ANTI-TUMOR ACTIVITY AND METABOLISM OF 5'-DEOXY-5-FLUOROURIDINE (DFUR) AND 5-FLUOROURACIL (FU) IN TRANSPLANTED TUMORS IN RODENTS
    RUSTUM, YM
    AU, JLS
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 303 - 303
12345